Astellas Pharma Inc's ticker is ALPMY and the CUSIP is 04623U102. A total of 13 filers reported holding Astellas Pharma Inc in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $235,000 | -5.2% | 14,222 | 0.0% | 0.07% | +4.2% |
| Q2 2021 | $248,000 | +13.2% | 14,222 | 0.0% | 0.07% | +7.6% |
| Q1 2021 | $219,000 | -0.5% | 14,222 | 0.0% | 0.07% | -14.3% |
| Q4 2020 | $220,000 | +4.3% | 14,222 | 0.0% | 0.08% | -10.5% |
| Q3 2020 | $211,000 | -27.2% | 14,222 | -18.3% | 0.09% | -28.9% |
| Q2 2020 | $290,000 | +6.2% | 17,402 | -1.5% | 0.12% | -13.6% |
| Q1 2020 | $273,000 | -10.2% | 17,669 | 0.0% | 0.14% | +18.6% |
| Q4 2019 | $304,000 | +20.6% | 17,669 | 0.0% | 0.12% | +10.3% |
| Q3 2019 | $252,000 | 0.0% | 17,669 | 0.0% | 0.11% | -0.9% |
| Q2 2019 | $252,000 | -7.0% | 17,669 | -2.3% | 0.11% | -12.2% |
| Q1 2019 | $271,000 | +17.3% | 18,078 | 0.0% | 0.12% | -18.0% |
| Q4 2018 | $231,000 | -12.2% | 18,078 | +20.1% | 0.15% | +51.5% |
| Q3 2018 | $263,000 | – | 15,052 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RENAISSANCE GROUP LLC | 1,006,415 | $15,080,000 | 0.60% |
| Henry James International Management Inc. | 18,078 | $271,000 | 0.12% |
| QUADRANT CAPITAL GROUP LLC | 27,557 | $407,000 | 0.07% |
| SCOUT INVESTMENTS, INC. | 210,640 | $3,156,000 | 0.06% |
| Aristotle Capital Management, LLC | 442,510 | $6,631,000 | 0.04% |
| BOSTON ADVISORS LLC | 43,966 | $658,000 | 0.03% |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 2,560,399 | $38,329,000 | 0.03% |
| GLENMEDE TRUST CO NA | 306,283 | $4,588,000 | 0.02% |
| FULTON BANK, N.A. | 14,909 | $223,000 | 0.02% |
| Front Row Advisors LLC | 1,101 | $16,000 | 0.01% |